摘要:One hundred and thirty-eight (138) patients, with five hundred and sixty-six (566) different burn sites with different degrees, severity and locations, were enrolled to a multicenter clinical trial at 25 study centers. The goal of this trial was to evaluate the efficacy of MEBO (Moist Exposed Burn Ointment) in the treatment of burn wound. Various parameters were studied including: (i) healing time, (ii) need for pain killers, (iii) consumption of i. v. Fluids, (iv) use of systemic antibiotics and (v) aesthetic appearance. There was remarkable decrease in the healing time and most patients either did not need any pain killer or were relieved with only mild analgesics, except in few cases of deep second degree and third degree burns. A decrease in the volume of i. v. fluids needed was also reported. Only 19% of cases developed clinical infection, especially in those who were not treated with MEBO immediately post burn. Even though systemic antibiotic treatment was prophylactically implemented in most cases as a routine measure, 32 cases did not receive any antibiotic prophylaxis with MEBO and yet did not develop any infection. The aesthetic appearance reported was very acceptable. This treatment modality was not associated with any side effects, and patient discomfort during application and change was negligible. Thus, MEBO treatment was associated with excellent and relatively faster healing, low incidence of wound infection, and excellent patient compliance.
摘要:Burn injuries are associated with anatomically within physiologically infections and biochemically within immunologically defect in hepatic functions during direct action on locally and systematic role of blood elements and liver enzymes. These defects represented the cellular response due to burn injuries. Aim of study: to assess the treatment and antioxidant action of MEBO ointment in medical therapy ,such as burn therapy. Methods: The study was performed by 66 burn patents(male) received treatment with ointment MEBO(100g)twice daily for two weeks and all patients have thickness burn injury, age ranged(15-65years for all subjects) and 50 men healthy control subjects ,So one day post burn samples were collected for hematological &biochemical parameters in kirkuk city at Azaadi hospital ,and this study done from march to December 2019 . Results: Leukocytes count (WBC), Neutrophil, lymphocyte,) and erythrocyte sedimentation rate ( ESR) were increased, while red blood cells count (RBC), hemoglobin (HB) were decreased after burn injury. Creatinine and potassium element are increased significantly, while Sodium element was decreased and significantly increased in the liver enzyme and glutathione after treatment when MDA significantly decreased .Conclusion: This study concluded that blood parameters and liver functions were altered due to burn injuries and these modulations attributable to the lipid peroxidation(MDA), while the liver enzyme signaling of hepatic activity for glutathione synthesis for curbing the free radicals after treatment by MEBO ointment ,this productive mechanism may be new defect liver mechanism for burn injury.
摘要:目的:观察MEBT/MEBO对大面积特重度烧伤病人的治疗效果。方法:全程采用MEBT/MEBO处理创面,小面积植皮。结果:60天创面完全愈合, 无功能障碍。结论:MEBT/MEBO治疗特重度烧伤疗效好,病程短,费用低,值得推广。
摘要:Hand burns predominantly affect young adults, and therefore have serious social and financial implications. In the present work, 106 patients with less than 25% body surface area burns and acute partial-thickness burned hands were managed using polyethylene bags and 1% local silver sulphadiazine (SSD) cream or moist exposed burn ointment (MEBO). Females made up 61.3% of the cases and flame burn was the majority cause (54.7%). There were no significant differences between the two groups regarding either the analgesic effect after local ointment application or hand movement inside the polyethylene bag. Local agent crustation over the wound was very evident in the hands managed by local 1% SSD cream (69.81%). On follow-up, the burned hands healed faster using local MEBO (10.48 versus 14.53 days), with fewer post-burn hand deformities and better active hand movements; however, the total cost until complete hand burn wound healing was higher with MEBO than with 1% SSD, although the final results were superior, with early return to work, when MEBO was used. We concluded that the use of MEBO as a topical agent and of polyethylene bags for the dressing of the acute partial-thickness burned hand accelerated healing; daily wound evaluation was easy as there was no crustation over it of the agent. It was more expensive than 1% SSD cream but presented fewer post-burn complications and more rapid healing, with shorter hospital stay.